4.5 Article

Real-time cell cycle imaging during melanoma growth, invasion, and drug response

期刊

PIGMENT CELL & MELANOMA RESEARCH
卷 27, 期 5, 页码 764-776

出版社

WILEY
DOI: 10.1111/pcmr.12274

关键词

melanoma heterogeneity; tumor microenvironment; cancer drug resistance; fluorescent ubiquitination-based cell cycle indicator; real-time imaging; migration; invasion

资金

  1. Cancer Council New South Wales [RG 09-08, RG 13-06]
  2. Priority-driven collaborative cancer research scheme/Cancer Australia/Cure Cancer Australia Foundation [570778, 1051996]
  3. Cancer Institute New South Wales [08/RFG/1-27]
  4. National Health and Medical Research Council [APP1003637]
  5. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/L002000/1] Funding Source: researchfish

向作者/读者索取更多资源

Solid cancers are composed of heterogeneous zones containing proliferating and quiescent cells. Despite considerable insight into the molecular mechanisms underlying aberrant cell cycle progression, there is limited understanding of the relationship between the cell cycle on the one side, and melanoma cell motility, invasion, and drug sensitivity on the other side. Utilizing the fluorescent ubiquitination-based cell cycle indicator (FUCCI) to longitudinally monitor proliferation and migration of melanoma cells in 3D culture and in vivo, we found that invading melanoma cells cycle actively, while G1-arrested cells showed decreased invasion. Melanoma cells in a hypoxic environment or treated with mitogen-activated protein kinase pathway inhibitors remained G1-arrested for extended periods of time, with proliferation and invasion resuming after re-exposure to a more favorable environment. We challenge the idea that the invasive and proliferative capacity of melanoma cells are mutually exclusive and further demonstrate that a reversibly G1-arrested subpopulation survives in the presence of targeted therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据